A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), a type of white blood cell. T lymphocytes (T cells) and B lymphocytes (B cells) are two types of white blood ...

The first treatment for diffuse large B-cell lymphoma is usually a combination of drugs known as R-CHOP This treatment cures about 60% of people who get it People who aren’t cured can get more chemo, ...

The main focus of this position is the creation and evaluation of spintronics-based neuromorphic computing devices (e.g., physical reservoir comput... Associate or Senior Editor (Ecology ...

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within ...

Polatuzumab targets a particular protein on B cell lymphoma cells. When polatuzumab attaches to these ... The combination of polatuzumab vedotin and RICE is new and the side effects aren’t yet known.

Medically reviewed by Gagandeep Brar, MD Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually ...

a malignancy of mature CD4 + T cells called adult T-cell leukemia-lymphoma (ATL) and a chronic inflammatory central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis ...